Ma. Mendall et al., SEROLOGY FOR HELICOBACTER-PYLORI COMPARED WITH SYMPTOM QUESTIONNAIRESIN SCREENING BEFORE DIRECT ACCESS ENDOSCOPY, Gut, 36(3), 1995, pp. 330-333
This prospective study aimed to compare serology for Helicobacter pylo
ri with two, symptom questionnaires in screening patients before direc
t access endoscopy. Methods were compared in terms of the number of en
doscopies saved and pathology missed in 315 patients referred to a gas
troenterology unit by 65 local GPs. The serology used was based on an
acid glycine extract of H pylori. One in-house questionnaire was based
on the Glasgow dyspepsia (GLADYS) system and the other questionnaire
was that reported by Holdstock et al. A cut off point of 6.3 U/ml for
H pylori serology was selected for screening patients (97% sensitive a
nd 75% specific). Serology was combined with a history of NSAID usage
in determining who should have endoscopy. For the inhouse questionnair
e, a cut off score of more than 8 out of a possible maximum of 18 was
chosen, after prior evaluation in 118 patients referred for direct acc
ess endoscopy (the sensitivity for detection of peptic ulcer was 88%,
specificity 61%). A cut off score of more than 412 was used for the Ho
ldstock questionnaire. In patients under 45 years, serology detected m
ore peptic ulcers than the in-house questionnaire and the Holdstock qu
estionnaire(27/28 v 24/28, NS and v 20/28, p<0.05 respectively). The H
oldstock questionnaire saved significantly more endoscopies than the o
ther two methods (76/149 v 57/149 for the in-house questionnaire, p=0.
05 and 59/149 for serology, p=0.05). In all age groups combined, serol
ogy was significantly better than the in-house and Holdstock questionn
aires at detecting peptic ulcers and gastric cancer (61/63, 52/63, p<0
.02, and 50/63, p<0.01 respectively). But serology saved significantly
fewer endoscopies (89/315, 135/315, p<0.005, and 119/315, p<0.05 resp
ectively). Serology was inferior to the Holdstock questionnaire at det
ecting severe oesophagitis. It is concluded that serology is the metho
d of choice in screening before direct access upper gastrointestinal e
ndoscopy in those under 45 years. It best combines a high sensitivity
for peptic ulcer disease with a large reduction in unnecessary negativ
e endoscopies.